Satri-cel, a CLDN18.2-targeted CAR T-cell therapy, nearly doubles progression-free survival in patients with previously ...

The “Two T’s in a Pod” co-host told listeners on Tuesday that her new beau is a “kind” and “private person” who “doesn’t have ...

The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — ...

For low-risk patients with papillary thyroid carcinoma interested in something other than surgery or surveillance, ...

The team has been awarded a $2.5 million grant to develop a system for inserting tiny light-emitting fibers directly into ...

Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced today the acquisition of Focal ...

Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025.

Anna Eberspacher was a competitive swimmer when she was diagnosed with cancer. But chemo and radiation treatments failed, and she had to have her leg amputated.

"Nobody knows for sure why colorectal cancer numbers are rising in young people." Scientists make disturbing discovery while ...

Cancer remains one of the major global health threats. Tumors are not only influenced by gut microbiota but can also actively ...

Doctors and scientists have been trying to understand why cancer spreads to certain organs, like the lungs or liver, more ...